Related Experiment Video
Updated: Jan 20, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
Decreased conformational stability in the oncogenic N92I mutant of Ras-related C3 botulinum toxin substrate 1
Yuki Toyama1,2, Kenji Kontani3, Toshiaki Katada4
1Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Abstract:
Ras-related C3 botulinum toxin substrate 1 (Rac1) functions as a molecular switch by cycling between an inactive guanosine diphosphate (GDP)-bound state and an active guanosine triphosphate (GTP)-bound state. An oncogenic mutant of Rac1, an N92I mutant, strongly promotes cell proliferation and subsequent oncogenic activities by facilitating the intrinsic GDP dissociation in the inactive GDP-bound state. Here, we used solution nuclear magnetic resonance spectroscopy to investigate the activation mechanism of the N92I mutant. We found that the static structure of the GDP binding site is not markedly perturbed by the mutation, but the overall conformational stability decreases in the N92I mutant, which then facilitates GDP dissociation by lowering the activation energy for the dissociation reaction. On the basis of these results, we proposed the activation mechanism of the N92I mutant, in which the decreased conformational stability plays important roles in its activation process.
Insights
An oncogenic Rac1 mutant (N92I) promotes cancer by enhancing GDP dissociation. This study reveals that decreased conformational stability, not altered GDP binding sites, drives this activation mechanism, offering new therapeutic targets.
Area of Science:
- Molecular biology
- Biochemistry
- Cellular signaling
Background:
- Ras-related C3 botulinum toxin substrate 1 (Rac1) acts as a molecular switch, cycling between GDP-bound (inactive) and GTP-bound (active) states.
- Oncogenic Rac1 mutants, like N92I, can drive uncontrolled cell proliferation and cancer development by altering this switching mechanism.
Purpose of the Study:
- To elucidate the molecular mechanism by which the N92I Rac1 mutant facilitates GDP dissociation and promotes oncogenic activity.
- To investigate the structural and dynamic changes associated with N92I mutant activation using biophysical techniques.
Main Methods:
- Solution nuclear magnetic resonance (NMR) spectroscopy was employed to study the GDP-bound N92I Rac1 mutant.
- Analysis focused on the structural integrity of the GDP binding site and overall protein conformational stability.
Main Results:
- The N92I mutation did not significantly alter the static structure of the GDP binding pocket.
- A decrease in the overall conformational stability of the N92I mutant was observed.
- This reduced stability lowers the activation energy for GDP dissociation, thereby accelerating the transition to the active state.
Conclusions:
- The oncogenic N92I Rac1 mutant activates through a mechanism primarily driven by decreased conformational stability, which facilitates GDP release.
- This finding highlights the importance of protein dynamics and stability in regulating Rac1 activity and its role in oncogenesis.
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Conformity
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Nuclear Stability
To hold positively charged protons together...
Decreased Body Temperature

